Alterity Therapeutics Limited (ATHE) Stock Price

1.96 ▼ -0.135 (-6.44%)
Open: 2.04 Vol: 109.7K Day's range: 1.70 - 2.14 Nov 13, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ATHE Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.89▲ 2.03▼ 2.03▼ 2.22▼ 2.25▼
MA10 2.02▼ 2.21▼ 2.21▼ 2.28▼ 2.95▼
MA20 2.20▼ 2.28▼ 2.30▼ 2.25▼ 3.86▼
MA50 2.34▼ 2.30▼ 2.33▼ 3.04▼ 3.80▼
MA100 2.33▼ 2.62▼ 2.82▼ 3.92▼ 3.97▼
MA200 2.79▼ 3.47▼ 3.76▼ 3.92▼ 3.12▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.038▼ -0.053▼ -0.050▼ 0.035▲ -0.262▼
RSI 40.329▼ 38.725▼ 38.663▼ 31.939▼ 28.366▼
STOCH 12.817▼ 10.229▼ 10.229▼ 19.821▼ 8.059▼
WILL %R -57.143     -68.421     -68.421     -83.642▼ -92.145▼
CCI -48.588     -108.566▼ -108.566▼ -158.263▼ -113.800▼
Latest Filters Detected On ATHE
▼ GAP $ATHE Open Gap Down %2 Set Alert
▼ BREAK $ATHE Price Breaks 60 Days Low Set Alert
▼ BREAK $ATHE Price Breaks 30 Days Low Set Alert
▼ BREAK $ATHE Price Breaks 20 Days Low Set Alert
▼ BREAK $ATHE Price Breaks 10 Days Low Set Alert
Alterity Therapeutics Limited News
Alterity Therapeutics to Present at the Virtual Bell Potter Healthcare Conference
Thursday, November 12, 2026 04:05 AM
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...
Alterity Therapeutics (ATHE) Presents Positive Phase 2 Data for ATH434
Tuesday, September 30, 2025 12:01 PM
Alterity Therapeutics Limited (NASDAQ:ATHE) is one of the best performing ASX stocks in 2025. On September 15, the company shared data from its Phase 2 clinical trial of the drug ATH434-201 at the ...
Alterity Therapeutics Limited (ATHE) Announces Positive Topline Data From Phase 2 Trial of ATH434 in Multiple System Atrophy
Saturday, August 16, 2025 10:56 PM
Alterity Therapeutics Limited (NASDAQ:ATHE) is among the 12 Best Australian Stocks to Buy Right Now. The company recently reported positive topline data from an open-label Phase 2 clinical trial of ...
ATHE historical stock data
date open high low close volume
13/11/26 2.04 2.14 1.70 1.96 109,700
12/11/26 2.28 2.28 2.04 2.095 71,596
11/11/26 2.2501 2.3605 2.2501 2.31 19,288
10/11/26 2.46 2.50 2.30 2.32 16,200
09/11/26 2.43 2.54 2.3801 2.43 9,936
06/11/26 2.35 2.45 2.35 2.43 13,400
05/11/26 2.35 2.58 2.17 2.22 39,681
04/11/26 2.47 2.65 2.37 2.44 120,500
03/11/26 2.10 3.2894 2.10 2.47 3,945,031
02/11/26 2.17 2.235 2.09 2.09 6,055
Quote Details
52wk Low:1.70
52wk High:5.892
Vol:109.7K
Avg Vol(3m):1.8M
1Y Chng:-41.32%
1M Chng:-39.13%
Add to Watch List
More Information
Index US Composite
Market Cap. 40.00M